Our results indicate that increased expression of ANXA3, ARG1 and HP can be detected in whole blood specimens both at and close to LC diagnosis beyond LC-associated changes in blood cell type proportions, and that these genes represent diagnostic and prognostic markers of late-stage LC. This evidence concerns the gene ARG1 and laryngotracheoesophageal cleft.